One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Gespeichert in:
Veröffentlicht in: | Journal of Virology 2011-08, Vol.85 (15), p.7582-7593 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7593 |
---|---|
container_issue | 15 |
container_start_page | 7582 |
container_title | Journal of Virology |
container_volume | 85 |
creator | DENTON, Paul W OTHIENO, Florence WELCH, Brett D KAY, Michael S PAYNE, Deborah A GALLAY, Philippe APPELLA, Ettore ESTES, Jacob D MIN LU VICTOR GARCIA, J MARTINEZ-TORRES, Francisco WEI ZOU KRISKO, John F FLEMING, Elisa ZEIN, Sima POWELL, Daniel A WAHL, Angela YOUN TAE KWAK |
description | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
doi_str_mv | 10.1128/JVI.00537-11 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_21593172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>875720100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-1006c08782a76d58b19cd1b70afefa18a0ee1df6a4825bd2f979ef9ce3de03b43</originalsourceid><addsrcrecordid>eNpVks9v0zAUxyMEYmNw44wsJMRlGXYSN85lUimFFhVWQVdxsxz7ufWU2MFOO8Z_zg33BwNOlt_7-H2_fvomyXOCLwjJ2JuPy-kFxjQvU0IeJKcEVyyllBQPk1OMsyylOft2kjwJ4QZjUhSD4nFykhFa5aTMTpNfVxbQHLwE26MFWKfd1ng07LrGgEIL1xkpmuYO9Q5NNq2w5mcsv50t0CcjAQmr0HWIlaGUzitjVzuwXwMaDedfpl-HCOMCjX904E0bJUSD3kEwKxuP1tnQe9FDQHPhexN7c-96kL1xFmnvWrQUK2NjfTJdoqnVh9Z5LDdGiX6vFqX2bpyCBmnn0Xgrmo3Yz3AafYbbnVPvaiONirai491bCE-TR1o0AZ4dz7Pk-v14MZqks6sP09FwlkpaVH1KMB5IzEqWiXKgKKtJJRWpSyw0aEGYwABE6YEoWEZrlemqrEBXEnIFOK-L_Cy5PMztNnULardoLxrexYUIf8edMPz_jjVrvnJbnpOirDIWB7w-DvDu-wZCz1sTJDSNsOA2gbOSlhmOPiN5fiDjf0PwoO9VCOa7sPAYFr4PS7xG_MW_zu7hP-mIwKsjIEJMgfbCShP-ckXOWF7lkXt54NZmtb41HrgILb_ZGs4oJ5SXlGX5b9BL10A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875720100</pqid></control><display><type>article</type><title>One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>DENTON, Paul W ; OTHIENO, Florence ; WELCH, Brett D ; KAY, Michael S ; PAYNE, Deborah A ; GALLAY, Philippe ; APPELLA, Ettore ; ESTES, Jacob D ; MIN LU ; VICTOR GARCIA, J ; MARTINEZ-TORRES, Francisco ; WEI ZOU ; KRISKO, John F ; FLEMING, Elisa ; ZEIN, Sima ; POWELL, Daniel A ; WAHL, Angela ; YOUN TAE KWAK</creator><creatorcontrib>DENTON, Paul W ; OTHIENO, Florence ; WELCH, Brett D ; KAY, Michael S ; PAYNE, Deborah A ; GALLAY, Philippe ; APPELLA, Ettore ; ESTES, Jacob D ; MIN LU ; VICTOR GARCIA, J ; MARTINEZ-TORRES, Francisco ; WEI ZOU ; KRISKO, John F ; FLEMING, Elisa ; ZEIN, Sima ; POWELL, Daniel A ; WAHL, Angela ; YOUN TAE KWAK</creatorcontrib><description>Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.00537-11</identifier><identifier>PMID: 21593172</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adenine - administration & dosage ; Adenine - analogs & derivatives ; Administration, Topical ; Animals ; Base Sequence ; Biological and medical sciences ; CD4-Positive T-Lymphocytes - immunology ; Chimera ; Disease Models, Animal ; DNA Primers ; Drug Evaluation, Preclinical ; Female ; Fundamental and applied biological sciences. Psychology ; HIV Infections - immunology ; HIV Infections - prevention & control ; HIV Infections - transmission ; Humans ; Mice ; Microbiology ; Miscellaneous ; Organophosphonates - administration & dosage ; Receptors, CCR5 - immunology ; Reverse Transcriptase Inhibitors - administration & dosage ; Tenofovir ; Vaccines and Antiviral Agents ; Vagina ; Virology</subject><ispartof>Journal of Virology, 2011-08, Vol.85 (15), p.7582-7593</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-1006c08782a76d58b19cd1b70afefa18a0ee1df6a4825bd2f979ef9ce3de03b43</citedby><cites>FETCH-LOGICAL-c549t-1006c08782a76d58b19cd1b70afefa18a0ee1df6a4825bd2f979ef9ce3de03b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147928/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147928/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24388393$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21593172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DENTON, Paul W</creatorcontrib><creatorcontrib>OTHIENO, Florence</creatorcontrib><creatorcontrib>WELCH, Brett D</creatorcontrib><creatorcontrib>KAY, Michael S</creatorcontrib><creatorcontrib>PAYNE, Deborah A</creatorcontrib><creatorcontrib>GALLAY, Philippe</creatorcontrib><creatorcontrib>APPELLA, Ettore</creatorcontrib><creatorcontrib>ESTES, Jacob D</creatorcontrib><creatorcontrib>MIN LU</creatorcontrib><creatorcontrib>VICTOR GARCIA, J</creatorcontrib><creatorcontrib>MARTINEZ-TORRES, Francisco</creatorcontrib><creatorcontrib>WEI ZOU</creatorcontrib><creatorcontrib>KRISKO, John F</creatorcontrib><creatorcontrib>FLEMING, Elisa</creatorcontrib><creatorcontrib>ZEIN, Sima</creatorcontrib><creatorcontrib>POWELL, Daniel A</creatorcontrib><creatorcontrib>WAHL, Angela</creatorcontrib><creatorcontrib>YOUN TAE KWAK</creatorcontrib><title>One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates</title><title>Journal of Virology</title><addtitle>J Virol</addtitle><description>Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
</description><subject>Adenine - administration & dosage</subject><subject>Adenine - analogs & derivatives</subject><subject>Administration, Topical</subject><subject>Animals</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Chimera</subject><subject>Disease Models, Animal</subject><subject>DNA Primers</subject><subject>Drug Evaluation, Preclinical</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Organophosphonates - administration & dosage</subject><subject>Receptors, CCR5 - immunology</subject><subject>Reverse Transcriptase Inhibitors - administration & dosage</subject><subject>Tenofovir</subject><subject>Vaccines and Antiviral Agents</subject><subject>Vagina</subject><subject>Virology</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVks9v0zAUxyMEYmNw44wsJMRlGXYSN85lUimFFhVWQVdxsxz7ufWU2MFOO8Z_zg33BwNOlt_7-H2_fvomyXOCLwjJ2JuPy-kFxjQvU0IeJKcEVyyllBQPk1OMsyylOft2kjwJ4QZjUhSD4nFykhFa5aTMTpNfVxbQHLwE26MFWKfd1ng07LrGgEIL1xkpmuYO9Q5NNq2w5mcsv50t0CcjAQmr0HWIlaGUzitjVzuwXwMaDedfpl-HCOMCjX904E0bJUSD3kEwKxuP1tnQe9FDQHPhexN7c-96kL1xFmnvWrQUK2NjfTJdoqnVh9Z5LDdGiX6vFqX2bpyCBmnn0Xgrmo3Yz3AafYbbnVPvaiONirai491bCE-TR1o0AZ4dz7Pk-v14MZqks6sP09FwlkpaVH1KMB5IzEqWiXKgKKtJJRWpSyw0aEGYwABE6YEoWEZrlemqrEBXEnIFOK-L_Cy5PMztNnULardoLxrexYUIf8edMPz_jjVrvnJbnpOirDIWB7w-DvDu-wZCz1sTJDSNsOA2gbOSlhmOPiN5fiDjf0PwoO9VCOa7sPAYFr4PS7xG_MW_zu7hP-mIwKsjIEJMgfbCShP-ckXOWF7lkXt54NZmtb41HrgILb_ZGs4oJ5SXlGX5b9BL10A</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>DENTON, Paul W</creator><creator>OTHIENO, Florence</creator><creator>WELCH, Brett D</creator><creator>KAY, Michael S</creator><creator>PAYNE, Deborah A</creator><creator>GALLAY, Philippe</creator><creator>APPELLA, Ettore</creator><creator>ESTES, Jacob D</creator><creator>MIN LU</creator><creator>VICTOR GARCIA, J</creator><creator>MARTINEZ-TORRES, Francisco</creator><creator>WEI ZOU</creator><creator>KRISKO, John F</creator><creator>FLEMING, Elisa</creator><creator>ZEIN, Sima</creator><creator>POWELL, Daniel A</creator><creator>WAHL, Angela</creator><creator>YOUN TAE KWAK</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110801</creationdate><title>One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates</title><author>DENTON, Paul W ; OTHIENO, Florence ; WELCH, Brett D ; KAY, Michael S ; PAYNE, Deborah A ; GALLAY, Philippe ; APPELLA, Ettore ; ESTES, Jacob D ; MIN LU ; VICTOR GARCIA, J ; MARTINEZ-TORRES, Francisco ; WEI ZOU ; KRISKO, John F ; FLEMING, Elisa ; ZEIN, Sima ; POWELL, Daniel A ; WAHL, Angela ; YOUN TAE KWAK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-1006c08782a76d58b19cd1b70afefa18a0ee1df6a4825bd2f979ef9ce3de03b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adenine - administration & dosage</topic><topic>Adenine - analogs & derivatives</topic><topic>Administration, Topical</topic><topic>Animals</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Chimera</topic><topic>Disease Models, Animal</topic><topic>DNA Primers</topic><topic>Drug Evaluation, Preclinical</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Organophosphonates - administration & dosage</topic><topic>Receptors, CCR5 - immunology</topic><topic>Reverse Transcriptase Inhibitors - administration & dosage</topic><topic>Tenofovir</topic><topic>Vaccines and Antiviral Agents</topic><topic>Vagina</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DENTON, Paul W</creatorcontrib><creatorcontrib>OTHIENO, Florence</creatorcontrib><creatorcontrib>WELCH, Brett D</creatorcontrib><creatorcontrib>KAY, Michael S</creatorcontrib><creatorcontrib>PAYNE, Deborah A</creatorcontrib><creatorcontrib>GALLAY, Philippe</creatorcontrib><creatorcontrib>APPELLA, Ettore</creatorcontrib><creatorcontrib>ESTES, Jacob D</creatorcontrib><creatorcontrib>MIN LU</creatorcontrib><creatorcontrib>VICTOR GARCIA, J</creatorcontrib><creatorcontrib>MARTINEZ-TORRES, Francisco</creatorcontrib><creatorcontrib>WEI ZOU</creatorcontrib><creatorcontrib>KRISKO, John F</creatorcontrib><creatorcontrib>FLEMING, Elisa</creatorcontrib><creatorcontrib>ZEIN, Sima</creatorcontrib><creatorcontrib>POWELL, Daniel A</creatorcontrib><creatorcontrib>WAHL, Angela</creatorcontrib><creatorcontrib>YOUN TAE KWAK</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DENTON, Paul W</au><au>OTHIENO, Florence</au><au>WELCH, Brett D</au><au>KAY, Michael S</au><au>PAYNE, Deborah A</au><au>GALLAY, Philippe</au><au>APPELLA, Ettore</au><au>ESTES, Jacob D</au><au>MIN LU</au><au>VICTOR GARCIA, J</au><au>MARTINEZ-TORRES, Francisco</au><au>WEI ZOU</au><au>KRISKO, John F</au><au>FLEMING, Elisa</au><au>ZEIN, Sima</au><au>POWELL, Daniel A</au><au>WAHL, Angela</au><au>YOUN TAE KWAK</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates</atitle><jtitle>Journal of Virology</jtitle><addtitle>J Virol</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>85</volume><issue>15</issue><spage>7582</spage><epage>7593</epage><pages>7582-7593</pages><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21593172</pmid><doi>10.1128/JVI.00537-11</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of Virology, 2011-08, Vol.85 (15), p.7582-7593 |
issn | 0022-538X 1098-5514 |
language | eng |
recordid | cdi_pubmed_primary_21593172 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adenine - administration & dosage Adenine - analogs & derivatives Administration, Topical Animals Base Sequence Biological and medical sciences CD4-Positive T-Lymphocytes - immunology Chimera Disease Models, Animal DNA Primers Drug Evaluation, Preclinical Female Fundamental and applied biological sciences. Psychology HIV Infections - immunology HIV Infections - prevention & control HIV Infections - transmission Humans Mice Microbiology Miscellaneous Organophosphonates - administration & dosage Receptors, CCR5 - immunology Reverse Transcriptase Inhibitors - administration & dosage Tenofovir Vaccines and Antiviral Agents Vagina Virology |
title | One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A55%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One%20Percent%20Tenofovir%20Applied%20Topically%20to%20Humanized%20BLT%20Mice%20and%20Used%20According%20to%20the%20CAPRISA%20004%20Experimental%20Design%20Demonstrates%20Partial%20Protection%20from%20Vaginal%20HIV%20Infection,%20Validating%20the%20BLT%20Model%20for%20Evaluation%20of%20New%20Microbicide%20Candidates&rft.jtitle=Journal%20of%20Virology&rft.au=DENTON,%20Paul%20W&rft.date=2011-08-01&rft.volume=85&rft.issue=15&rft.spage=7582&rft.epage=7593&rft.pages=7582-7593&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.00537-11&rft_dat=%3Cproquest_pubme%3E875720100%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875720100&rft_id=info:pmid/21593172&rfr_iscdi=true |